HomeEducationCOURSE CATALOGCourse Detail

Probiotics in the NICU: Evidence & Experience

Program Date: 29 September 2021

Publication Date: 9 December 2021

Continuing Education Units: Nurse Contact: 0.5; Dietitian CPEU: 0.5

Course Description:

In this course, you’ll learn the definition of dysbiosis and the risk factors for the preterm infants; review the expert body of recommendations regarding the use of probiotics; and discuss the process for selecting, implementing, and monitoring a probiotic supplement at your institution. Originally presented as a live webinar on September 29, 2021.

Course Objectives:

• Define dysbiosis and the risk factors for the preterm infants.

• Review the expert body of recommendations regarding the use of probiotics.

• Discuss the process for selecting, implementing, and monitoring a probiotic supplement at your institution.

CDR Level: 2
Performance Indicators: 4.1.2, 8.1.5, 8.2.2
Run Time: 40

Course Instructor Bio(s)

Arpitha Chiruvolu, MD, FAAP

Neonatologist, Baylor Scott & White University Medical Center

Medical Director, NICU, Baylor Scott & White Medical Center

Clinical Associate Professor, Texas A&M College of Medicine

Dallas, TX, USA

Dr Arpitha Chiruvolu, MD, FAAP, is a Neonatologist with over 15 years’ experience, currently practicing at Baylor Scott & White University Medical Center at Dallas, Texas. She is the Medical Director of Neonatal Intensive Care Unit at Baylor Scott & White Medical Center – McKinney, Texas and also serves as Clinical Associate Professor at Texas A&M College of Medicine. Dr Chiruvolu received numerous teaching and service awards including Physician of the Year 2018-19 award from Baylor Scott & White Health and was nominated for Dallas Fort Worth Hospital Council Employee (Physician) of the Year Award 2019. Dr Chiruvolu performs clinical research focusing on newborn resuscitation, preterm sepsis, antibiotic stewardship, and quality improvement. She presented her research at multiple national and international conferences and has authored over 25 peer-reviewed articles published in top-tier journals.

Adam Baker, PhD

Director of Science, Human Health

Christian Hansen Human Health

Hørsholm, Denmark

Dr Baker leads the Human Health and Microbiome Research and Development team who are responsible for the research of current and next-generation probiotics, and the development of technical in vitro and in vivo discovery platforms for mode of action research. Prior to Chr. Hansen, he worked as the VP of Diagnostic Product Development at Exiqon A/S in Denmark for 5 years and the Head of New Technologies in deCODE Genetics in Iceland. Both roles focused on the development of new insights and therapeutics to support the clinical treatment of complex diseases. In addition, Dr Baker has held positions in Vancouver, Canada and Boehringer Ingelheim in Vienna Austria.

Karyn Wulf, MD, MPH

Medical Director, Pediatrics

Abbott Nutrition Products Division

Columbus, Ohio, USA

Dr Karyn Wulf joined Abbott Nutrition as Pediatric Medical Director in 2018 after working clinically for 16 years as a general pediatrician in emergency medicine. She maintains her clinical activities on a part-time basis. She attended the University of Pittsburgh School of Medicine with a dual degree in Medicine and Public Health in 1999. She completed her internship and residency in general pediatrics at The Johns Hopkins Hospital in 2002. During her clinical practice, Dr Wulf was actively involved in medical education and taught medical students, residents and faculty and held faculty appointments at Baylor College of Medicine (2007-2009) and The Ohio State University School of Medicine (2009-2018). Her research interests include pediatric malnutrition screening and mentoring best practices for women in medicine and science.